Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.0K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UCHL1-Related Dominant Optic Atrophy: Report of Two New Families.

Neuro-ophthalmology (Aeolus Press)·2026
Same author

Australian parents' perspectives on extended genomic screening: what information to return and when?

European journal of human genetics : EJHG·2026
Same author

Automated reanalysis of genomic data for rare disease diagnostics at scale.

Nature medicine·2026
Same author

Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing.

European journal of human genetics : EJHG·2026
Same author

Gene-disease relationships for glomerular phenotypes: expert recommendations from ClinGen.

Nature reviews. Nephrology·2026
Same author

Genomic newborn screening: a scoping review of the field's evolution and associated ethical, legal, and social implications.

European journal of human genetics : EJHG·2026

Related Experiment Video

Updated: Jul 25, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.1K

Genomic newborn screening for rare diseases.

Zornitza Stark1,2,3, Richard H Scott4,5,6

  • 1Australian Genomics, Melbourne, Victoria, Australia. zornitza.stark@vcgs.org.au.

Nature Reviews. Genetics
|June 29, 2023
PubMed
Summary

Genomic sequencing in newborn screening can rapidly diagnose rare diseases, improving infant health outcomes. Further research is needed to address ethical considerations and demonstrate long-term benefits.

More Related Videos

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.9K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K

Related Experiment Videos

Last Updated: Jul 25, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.1K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.9K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

8.7K

Area of Science:

  • Genetics
  • Public Health
  • Medical Diagnostics

Background:

  • Rare diseases cause significant infant mortality and disability.
  • Genomic sequencing offers rapid, accurate, and cost-effective genetic diagnoses.
  • Timely diagnosis and treatment are crucial for improving rare disease outcomes.

Purpose of the Study:

  • To review the challenges and opportunities of integrating genomic sequencing into population-scale newborn screening programs.
  • To highlight the need for evidence generation regarding the benefits of newborn genomic screening.
  • To address the ethical, legal, and psychosocial implications of newborn genomic screening.

Main Methods:

  • Review of current international large-scale newborn genomic screening projects.
  • Analysis of the potential benefits of stored genomic data for lifelong health and research.
  • Examination of ethical, legal, and psychosocial considerations.

Main Results:

  • Genomic sequencing can expand early detection of treatable rare diseases.
  • Stored genomic data may offer long-term health benefits and support research.
  • Significant ethical, legal, and psychosocial challenges must be addressed.

Conclusions:

  • Newborn genomic screening holds promise for early detection of rare diseases.
  • Evidence of benefit and robust ethical frameworks are essential for implementation.
  • Addressing multifaceted challenges is critical for successful population-scale genomic screening.